Interferon-driven alterations of the host's amino acid metabolism in the pathogenesis of typhoid fever.

Address: Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford OX3 7LE, England, UK [email protected].; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford OX3 7LE, England, UK.; Center for Vaccines and Immunity, The Research Institute at Nationwide Children's Hospital, The Ohio State University College of Medicine, Columbus, OH 43210.; Nuffield Department of Medicine, University of Oxford, OX1 2JD, England, UK.; Microbial Pathogenesis Group, The Wellcome Trust Sanger Institute, Hinxton CB10 1SA, England, UK.; Proteomic Mass Spectrometry, The Wellcome Trust Sanger Institute, Hinxton CB10 1SA, England, UK.; Nuffield Department of Primary Care Health Sciences, University of Oxford, OX1 2JD, England, UK.; Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD 21201.; Emergent Product Development UK, Emergent BioSolutions, Wokingham RG41 5TU, England, UK.; EMBL Australia Group, South Australian Health and Medical Research Institute, North Terrace, Adelaide, SA 5000, Australia School of Medicine, Flinders University, Bedford Park, SA 5042, Australia.